PHVS
Pharvaris BV
NASDAQ: PHVS · HEALTHCARE · BIOTECHNOLOGY
$30.09
+1.38% today
Updated 2026-05-08
Market cap
$1.97B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.48
Dividend yield
—
52W range
$15 – $31
Volume
0.3M
Pharvaris BV (PHVS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $4.80M | $5.43M | $20.60M | $101.10M | $212.09M | $167.73M | $398.69M | $291.37M |
| Cash & equivalents | $4.80M | $5.39M | $20.33M | $98.63M | $209.35M | $161.84M | $391.23M | $280.73M |
| Current assets | $4.80M | $5.43M | $20.58M | $100.95M | $211.57M | $166.85M | $397.85M | $289.42M |
| Total liabilities | $138836.00 | $481340.00 | $1.92M | $5.31M | $7.14M | $18.47M | $14.65M | $23.61M |
| Current liabilities | $138836.00 | $481340.00 | $1.92M | $5.31M | $6.99M | $18.22M | $14.60M | $22.97M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Shareholder equity | $4.66M | $4.95M | $18.67M | $95.79M | $204.95M | $149.26M | $384.05M | $267.76M |
| Retained earnings | $-6.13M | $-10.45M | $-18.47M | $-44.46M | $-87.57M | $-164.19M | $-265.92M | $-402.26M |
| Accounts receivable | $1056.00 | $26423.00 | $210843.00 | $569578.00 | $700079.00 | $382468.00 | $1.04M | $2.94M |
| Inventory | — | — | — | $540701.00 | $1.51M | $4.04M | $-322558.00 | — |
| Goodwill | — | — | — | — | — | — | — | — |